Is this the short squeeze that we've been hearing so much about? Looks like its almost over and no price appreciation.
I agree. HIFU division sales will not take off until Focal One is approved in the US. Maybe Late summer, or early fall
Co2 makes the earth greener.
It doesn't seem like the backlog went down much. Are there new orders?
A couple of months ago, EDAP announced Focal One approval in Russia, but I haven't heard any sales announced there.
When the FDA is involved - everybody waits. Not too many are dying from Prostrate cancer. They just cut it out.
Nobody is going to buy the robotic albatherm. They will wait for the Focal One. Sales in the HIFU division will be lackluster until then.